Skip to main content
. 2020 Nov 20;11(11):995. doi: 10.1038/s41419-020-03205-2

Fig. 4. ASB16-AS1 regulates CDK6 and IGF1R mRNAs expression in adrenocortical carcinoma cells.

Fig. 4

a Heatmap of RNA transcriptome sequencing upon inhibition of ASB16-AS1 expression. SW-13 adrenocortical carcinoma cells were transfected with ASB16-AS1 siRNA2 and RNA sequencing was performed 48 h post-transfection. b Gene ontology (GO) analysis of up-regulated genes when the expression of ASB16-AS1 is inhibited. c, d Inhibition of ASB16-AS1 up-regulates CDK6 and IGF1R mRNAs expression. ASB16-AS1 siRNA1 (siRNA1) or ASB16-AS1 siRNA2 (siRNA2) was transfected into adrenocortical carcinoma cell SW-13 or H295R cells and qRT-PCR was performed to analyze the expression of CDK6 and IGF1R expressions 48 h post transfection. *P < 0.05 versus NC group. e Inhibition of ASB16-AS1 up-regulates the protein levels of CDK6 and IGF1R. ASB16-AS1 siRNA1 (si1) or ASB16-AS1 siRNA2 (si2) was transfected into SW-13 or H295R cells, the protein levels of CDK6 and IGF1R were analyzed by western blot. f Immunohistochemical staining of CDK6 and IGF1R in sections from xenograft tumors stably expressing ASB16-AS1. Scale bar equals 100 μm. The experiments were performed in triplicate. The data are represented as mean ± SEM from three independent experiments.